Evidence map›Paper›PMID 22522471›Full record

ArticleNeuroscience2012

Rapamycin attenuates aggressive behavior in a rat model of pilocarpine-induced epilepsy.

X Huang, J McMahon, Y Huang

Abstract read
In one paragraph

Article in Neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. A novel AAV9-dual microRNA-vector targetingMolecular therapy. Methods & clinical development · 2024
    Article
  3. Investigations on the Ability of the Insular Cortex to Process Peripheral Immunosuppression.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Behavioral, metabolic, and renal outcomes of 1-month isolation in adolescent male Dahl salt-sensitive rats.American journal of physiology. Regulatory, integrative and comparative physiology · 2020
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

X HuangCenter for Neuropharmacology and Neuroscience, Albany Medical College, NY, USA.
J McMahon
Y Huang
Albany Medical Center Hospital · US

Funding

The mTOR pathway in neuronal death and epileptogenesisR01NS062068 · NINDS · ALBANY MEDICAL COLLEGE · PI HUANG, YUNFEI · 2008 to 2011
$1.2M
NINDS NIH HHS NS062068NINDS NIH HHS R01 NS062068
6 · The paper itself

Abstract

Psychiatric disorders are fairly common comorbidities of epilepsy in humans. Following pilocarpine-induced status epilepticus (SE), experimental animals not only developed spontaneous recurrent seizures, but also exhibited significantly elevated levels of aggressive behavior. The cellular and molecular mechanism triggering these behavioral alterations remains unclear. In the present study, we found that aggression is positively correlated with development of spontaneous seizures. Treatment with rapamycin, a potent mTOR (mammalian target of rapamycin pathway)-pathway inhibitor, markedly diminished aggressive behavior. Therefore, the mTOR pathway may have significance in the underlying molecular mechanism leading to aggression associated with epilepsy.

Indexed as

AggressionAnimalsBehavior, AnimalDisease Models, AnimalImmunosuppressive AgentsPhysical StimulationPilocarpineRatsRats, Sprague-DawleySirolimusStatus EpilepticusTouchImmunosuppressive AgentsPilocarpineSirolimus

Identifiers

PMID22522471
PMCPMC3371158
OpenAlexW2025256786

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.